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Summary
Mutations in the transcriptional repressor, methyl-CpG
binding protein 2 (MeCP2), result in a neurodevelop-
mental disorder called Rett Syndrome (RTT) [1–5].
Based on the neurological phenotypes observed in
Rett patients, we examined the potential role of
MeCP2 in synaptic function. We compared elementary
properties of synaptic transmission between cultured
hippocampal neurons from MeCP2 knockout and
wild-type littermate control mice and found a decrease
in the frequency of spontaneous excitatory synaptic
transmission (mEPSCs) in neurons lacking MeCP2.
We also detected a significant increase in the rate of
short-term synaptic depression. To explore whether
these functional effects can be attributed to MeCP2’s
role as a transcriptional silencer, we treated cultures
with a drug that impairs histone deacetylation and ex-
amined spontaneous synaptic transmission. Treat-
ment with this compound induced a similar decrease
in mEPSC frequency in wild-type control cultures, but
this decrease was occluded in MeCP2-deficient neu-
rons. Interestingly, neither the loss of MeCP2 nor the
drug treatment resulted in changes in mIPSC proper-
ties. Finally, by means of a lentivirus expressing Cre re-
combinase, we show that loss of MeCP2 function after
neurodevelopment and synaptogenesis was sufficient
to mimic the decrease in mEPSC frequency seen in
constitutive MeCP2 KO neurons. Taken together, these
results suggest a role for MeCP2 in control of excitatory
presynaptic function through regulation of gene ex-
pression.
Results
Decrease in the Frequency of mEPSCs in MeCP2
Knockout Neurons
To elucidate the role of MeCP2 in the regulation of synap-
tic transmission, we studied functional alterations of
synapses in 11–14 days in vitro hippocampal cultures
made from newly born MeCP2 KO mice. Recent electro-
physiological measurements of synaptic plasticity in
MeCP2-deficient mice were performed on both hip-
pocampal and cortical slices [6, 7]. Dissociated primary
cultures allow examination of synaptic function in-
dependent of potential general alterations in brain ho-
meostasis, thereby enabling a distinction between
*Correspondence: lisa.monteggia@utsouthwestern.educell-autonomous defects and global systemic dysfunc-
tion. We quantified the frequency and amplitude of spon-
taneous miniature excitatory postsynaptic currents
(mEPSCs) in MeCP2 KO and wild-type (wt) littermate
control cultures by means of whole-cell recordings per-
formed in the presence of tetrodotoxin (TTX) to block ac-
tion potential firing and picrotoxin to block inhibitory ac-
tivity. We found a significant decrease in the frequency of
mEPSCs in the KO neurons compared to wt controls
(Figures 1A–1C). The decrease was also observed in
older cultures (>20 DIV; data not shown), suggesting
that the loss of MeCP2 produces long-term alterations
in excitatory synaptic transmission. This alteration in
mEPSC frequency may implicate a presynaptic deficit
in the MeCP2 KO neurons. In contrast, the frequency of
spontaneous miniature inhibitory postsynaptic currents
(mIPSCs) was unaffected, suggesting a specificity of
MeCP2 function in excitatory neurotransmission (Fig-
ures 1E–1G). The amplitudes of individual synaptic
events in both mEPSCs and mIPSCs were also unaf-
fected by the loss of MeCP2, indicating no change in
the number of postsynaptic receptors at either excit-
atory or inhibitory synapses (Figures 1D and 1H).
To better understand how the loss of MeCP2 may con-
tribute to the alteration in mEPSC frequency, we exam-
ined the number of presynaptic terminals formed on
pyramidal neuron dendrites in culture. Neurons were im-
munostained for microtubule-associated protein (MAP2)
and synapsin, a synaptic vesicle protein, to identify pre-
synaptic terminals on the dendrites and soma. This anal-
ysis revealed that the number of presynaptic terminals
was unchanged in MeCP2 KO neurons compared with
wt neurons, suggesting that the decrease in spontane-
ous synaptic events is not the result of a decreased num-
ber of presynaptic terminals (Figures 1I and 1J).
Characterization of Spontaneous and Evoked
Neurotransmission in MeCP2-Deficient Cultures
We next examined whether there was a decrease in the
size of the total recycling pool and the number of readily
releasable vesicles (see Figure S1 in the Supplemental
Data available with this article online). To probe the total
pool size, we stimulated cultures with 47 mM K+ solution
for 90 s in the presence of the styryl dye FM1-43 [8]. This
strong stimulation normally labels all recycling vesicles
within a presynaptic terminal [9]. After dye wash out
(w10 min), we stimulated the cultures with 90 mM K+ so-
lution applied four times, the first for 90 s followed by
three applications of 60 s each (each separated by 60 s
intervals), to release all the dye trapped within presynap-
tic terminals. The kinetics of dye loss from synaptic ter-
minals (Figure S1A) and the total amount of dye trapped
in individual synapses was indistinguishable between
KO and control neurons (Figure S1B), indicating that
the sizes of the total vesicle pools were unchanged. To
quantify differences in the number of readily releasable
vesicles, we stimulated cultures with a brief hypertonic
sucrose application, which selectively releases vesicles
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711Figure 1. Spontaneous Miniature Synaptic Currents in Cultured Hip-
pocampal Neurons from MeCP2 Knockout and Control Mice
(A–D) Spontaneous excitatory synaptic currents. Representative re-
cordings of miniature excitatory events in control (A) and MeCP2
knockout (B) neurons recorded in 1 mM TTX and 50 mM picrotoxin.
(C) Bar graph showing a decrease in the frequency of spontaneous
excitatory events in knockout neurons compared to controls (*p <
0.05). (D) Cumulative histogram of mEPSC amplitudes.
(E–H) Spontaneous inhibitory synaptic currents. Representative re-
cordings of miniature inhibitory events in control (E) and MeCP2
knockout (F) neurons recorded in 1 mM TTX and 10 mM NBQX. (G)
Bar graph showing similar frequencies of spontaneous inhibitoryfrom the readily releasable pool [10]. We found no differ-
ence between the MeCP2 KO and wt neurons, suggest-
ing that the changes in spontaneous release frequency in
the KO cultures cannot be attributed to a reduction in the
number of readily releasable vesicles (Figures S1C and
S1D). However, we cannot fully exclude the possibility
that the numbers of spontaneously recycling vesicles
are reduced, but we consider this unlikely given that
sizes of distinct vesicle pools are usually highly corre-
lated in central synapses [11].
We next examined the properties of evoked neuro-
transmission in response to action potential stimulation.
Trains of action potentials applied at 10 Hz typically de-
press neurotransmission. This depression is, at least in
part, elicited by a rapid decrease in the number of vesi-
cles available for release within a synaptic terminal.
When the kinetics of synaptic depression and recovery
in the MeCP2 KO cultures were examined, we observed
a more rapid depression during 10 Hz stimulation and
a slower response recovery when the stimulation fre-
quency was switched to 1 Hz at the end of the 10 Hz train
compared to wt cultures (Figures 2A, 2C, and 2D). The
KO cultures also showed a slight increase in first re-
sponse amplitudes at 10 Hz and significantly smaller
paired pulse ratios during high-stimulation frequencies
compared to controls (Figures 2B, 2C, and insert). These
findings suggest that the loss of MeCP2 may contribute
to an increase in neurotransmitter release probability
leading to a faster depletion of releasable vesicles, as
well as a delay in synaptic vesicle recycling after stimula-
tion retarding the recovery of responses. Taken together
with the decrease in spontaneous event frequency,
these findings suggest a role for MeCP2 in presynaptic
control of neurotransmitter release and vesicle recy-
cling.
Inhibition of Transcriptional Silencing Decreases
mEPSC Frequency
To examine whether the alterations in excitatory neuro-
transmission of neurons lacking MeCP2 are the result
of impairments in gene silencing, we treated wild-type
C57BL/6 hippocampal cultures chronically with drugs
that inhibit either transcriptional activation or repression
and then measured synaptic transmission. To suppress
transcription, we treated cultures with the RNA polymer-
ase inhibitor Actinomycin-D. To suppress transcriptional
repression, we used Trichostatin A (TSA), a histone de-
acetylase inhibitor. Cultures were treated with these indi-
vidual drugs (and DMSO as a control) for 24 hr and then
synaptic activity was measured. We preferred chronic
rather than acute treatments because earlier studies
did not reveal a significant change in baseline synaptic
events in control and knockout neurons. (H) Cumulative histogram
of mIPSC amplitudes.
(I and J) Immunostaining of cultured neurons. (I) Dissociated neu-
rons from control and knockout mice were labeled with primary
antibodies to MAP2 (green) and Synapsin (red). (J) Bar graph de-
picts the number of presynaptic terminals found in control and
mutant neurons. There was no significant difference in the number
of presynaptic terminals between control and MeCP2 knockout
neurons (p > 0.2).
Error bars show standard error of the mean.
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712Figure 2. Evoked Synaptic Responses in MeCP2 Knockout and Control Neurons during 10 Hz Field Stimulation Immediately Followed by 1 Hz
Recovery Stimulation
(A) Representative whole-cell recordings of the first 20 responses.
(B) Paired pulse ratios of the first two responses during various stimulation frequencies were measured from control and knockout neurons. The
paired pulse ratios recorded from MeCP2 knockout neurons were significantly less than control at both 30 Hz and 10 Hz frequencies (*p < 0.05;
**p < 0.01).
(C) Average response amplitudes of control and mutant neurons measured during the first 2 s of 10 Hz stimulation. Recorded responses from
field stimulated knockout neurons depressed significantly faster than control responses (*p < 0.05; **p < 0.01). Insert is a bar graph depicting
similar average first peak amplitudes of these responses.
(D) Average response amplitudes measured during 1 Hz stimulation following the 10 Hz depression. Knockout response amplitudes did not re-
cover as quickly as those recorded from control neurons (*p < 0.05).
Error bars show standard error of the mean.transmission after acute TSA application, although they
reported a strong augmentation of long-term synaptic
plasticity [12]. We initially examined cell viability in the
presence of these chronic treatments and found that it
was not compromised (see Experimental Procedures).
In these experiments, we focused on potential alter-
ations in the frequency and amplitude of spontaneous
miniature events, which is a more direct measurement
of presynaptic machinery, since evoked transmission
may be vulnerable to alterations in membrane excitabil-
ity and Ca2+ signaling, two aspects of neuronal function
that may also be targeted by transcriptional regulation.
We found a significant decrease in mEPSC frequency
in TSA-treated cultures compared to DMSO-treated cul-
tures, while Actinomycin-D did not have an effect (Fig-
ures 3A and 3B). The average amplitudes of individual
events were not significantly affected by these treat-
ments (data not shown). We also determined the number
of presynaptic terminals in these cultures and found no
changes between the control and TSA treatment (Fig-
ures 3C and 3D). Similarly to what was seen with the
MeCP2 KO cultures, both the frequency and amplitudes
of mIPSCs were unchanged between the DMSO- andTSA-treated neurons (Figures 3E and 3F and data not
shown). To investigate whether newly transcribed genes
are involved in the suppression of synaptic function, we
treated cultures with both Actinomycin-D and TSA and
found a reversal of the mEPSC deficits seen in the TSA-
treated neurons (Figure 3B). These findings indicate a
selective impairment of excitatory presynaptic function
after suppression of transcriptional repression but not
transcriptional activation.
To examine whether the TSA-mediated decrease in
mEPSCs was related to MeCP2 function, we chronically
treated MeCP2 KO cultures with TSA and did not detect
a reduction in the frequency of spontaneous mEPSCs
(Figures 3G and 3H). This result strongly suggests that
the decrease in spontaneous miniature frequency we ob-
served in the presence of this transcriptional activator
was in significant part due to inhibition of MeCP2 func-
tion and thus was occluded in the absence of MeCP2. In-
terestingly, Actinomycin-D did not rescue the reduction
in mEPSC frequency seen in MeCP2 KOs back to control
levels (Figures 3G and 3H). This may not be surprising
since degradation of abnormally expressed presynaptic
proteins may take longer than 24 hr.
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713Figure 3. Spontaneous Miniature Synaptic Responses from Wild-
Type C57BL/6 and MeCP2 Knockout Hippocampal Cultures after
a 24 hr Treatment with Inhibitors of Transcriptional Repression
and Activation
(A and B) Spontaneous excitatory synaptic currents from C57BL/6
neurons. (A) Representative miniature excitatory synaptic currents
from drug-treated neurons recorded in 1 mM TTX and 50 mM picro-
toxin. (B) Bar graph of the significant decrease in mEPSC frequencies
in neurons treated for 24 hr with the inhibitor of transcriptional repres-
sion, TSA (*p < 0.05). This decrease was reversed when treatment in-
cluded both TSA and the inhibitor of transcriptional activation, Act D.
(C and D) Immunostaining of C57BL/6 cultured neurons. (C) Control
and TSA-treated dissociated neurons were labeled with primary an-
tibodies to MAP2 (green) and Synapsin (red). (D) Bar graph depicting
a similar number of presynaptic terminals found in control and TSA-
treated neurons.
(E and F) Spontaneous inhibitory synaptic currents from C57BL/6
neurons. (E) Representative recordings of miniature inhibitory events
from control and TSA-treated neurons recorded in 1 mM TTX and 10
mM NBQX. (F) Bar graph showing the frequencies of spontaneous
miniature inhibitory events.
(GandH)Spontaneousexcitatorysynapticcurrents fromMeCP2knock-
out neurons. (G) Representative traces from drug-treated knockout neu-
rons recorded in the presence of 1mM TTX and 50mM picrotoxin. (H) Bar
graph showing that mEPSC frequencies in knockout neurons were
not significantly affected by 24 hr treatment with either Act D or TSA.
Error bars show standard error of the mean.Alterations in mEPSC Frequency in Floxed MeCP2
Neurons Infected with a Lentivirus Expressing
Cre Recombinase
We also investigated whether an acute loss of MeCP2
function after neurodevelopment and synapse matura-
tion would result in similar phenotypes found in the
constitutive MeCP2 KO neurons. We made primary dis-
sociated hippocampal cultures from newborn floxed
MeCP2 mice and allowed them to age 7 days in vitro be-
fore infecting them with high or low titer lentivirus
expressing the gene Cre recombinase, or GFP as a con-
trol. One week later, we found a significant decrease in
the frequency of mEPSCs in high titer Cre-infected
floxed MeCP2 neurons compared to GFP-infected neu-
rons (Figures 4A and 4B). This significant frequency de-
crease was also seen when mEPSCs from Cre-infected
floxed MeCP2 neurons were compared with Cre-in-
fected wild-type littermate neurons, ruling out a nonspe-
cific effect of Cre expression on mEPSCs (Figures 4A and
4B). These data suggest that MeCP2 acts as a regulator
of synaptic transmission even in mature neurons and the
loss of MeCP2 may have profound effects on synaptic
function after neurodevelopment. We also recorded
mEPSCs from uninfected floxed MeCP2 neurons receiv-
ing the majority of their inputs from Cre-infected neurons
and found the same decrease in event frequency sup-
porting the presynapticorigin of this observation (Figures
4A and 4B). In accordance with this premise, mEPSC
frequency was not altered in floxed MeCP2 neurons in-
fected with a low titer Cre-expressing lentivirus com-
pared to GFP controls (Figures 4D and 4E). These data,
as well as the fact that we saw no significant changes in
mEPSC amplitudes among any of the lentiviral infected
cultures (Figures 4C and 4F), strongly suggest that
MeCP2 plays a specific role in presynaptic function.
Discussion
Taken together, these findings suggest that synaptic
transmission, in particular presynaptic function, is under
transcriptional control and that MeCP2-dependent
transcriptional repression is a critical component of this
regulation. In our experiments, we detected MeCP2-
dependent alterations in spontaneous neurotransmission
as well as in short-term synaptic depression. Spontane-
ous neurotransmission is important for a number of neu-
ronal processes, which include maturation and stability
of synaptic networks [13, 14] and inhibition of local den-
dritic protein synthesis [15]. Therefore, the decrease in
mEPSCs we describe here may well underlie some of
the neuromorphological abnormalities seen in RTT pa-
tients as well as RTT mouse models [16–19]. However,
our data also suggest genes involved in evoked trans-
mission and short-term plasticity as potential transcrip-
tional targets under MeCP2 control. Short-term synaptic
depression is a fundamental synaptic mechanism, which
underlies key brain functions such as sound localization
and sensory adaptation [20–22]. Therefore, changes in
synaptic depression may have important implications
for the synaptic basis of RTT as well as other neurode-
velopmental disorders.
Recent evidence suggests that synaptic vesicles giv-
ing rise to evoked and spontaneous neurotransmis-
sion originate from different pools [11]. Therefore, it is
Current Biology
714Figure 4. Spontaneous Miniature Excitatory
Synaptic Currents in Floxed MeCP2 Neurons
Infected with a Lentivirus Expressing Cre Re-
combinase
(A–C) Miniature excitatory events from floxed
neurons infected with high titer lentivirus. (A)
Representative traces from infected neurons
recorded in the presence of 1 mM TTX and 50
mM picrotoxin. (B) Bar graph revealing a sig-
nificant decrease in mEPSC frequencies
from floxed MeCP2 neurons infected after
synapse formation with high titer lentiviral
Cre recombinase (*p < 0.05). This decrease
was seen in recordings from both Cre-
infected and uninfected postsynaptic floxed
neurons and is compared to both floxed neu-
rons infected with GFP and wild-type neu-
rons infected with Cre. (C) Cumulative histo-
gram showing no significant changes in
mEPSC amplitudes.
(D–F) Miniature excitatory currents from
floxed neurons infected with low titer lentivi-
rus. (D) Representative traces of mEPSCs
recorded from infected neurons. (E) Bar
graph revealing similar mEPSC frequencies
from floxed MeCP2 neurons infected after
synapse formation with low titer lentiviral
Cre recombinase (*p < 0.05). (F) Cumulative
histogram showing no significant changes in
mEPSC amplitudes.
Error bars show standard error of the mean.possible to envision that simultaneous changes in ex-
pression levels of multiple synaptic proteins, which are
under MeCP2 regulation, may have opposing effects
(or a complex additive effect) on the two forms of neuro-
transmission. Understanding the mechanisms underly-
ing these synaptic alterations will require identification
of synaptic molecules that are MeCP2 dependent in their
transcription.
Could the alterations in synaptic transmission pro-
duced by mutations in the MeCP2 gene underlie the be-
havioral phenotypes observed in RTT patients? Recent
studies have shown that the loss of MeCP2 selectively
in the brain is sufficient to recapitulate many features of
RTT, including impaired motor coordination, increased
anxiety-related behavior, and social deficits [23]. In re-
lated studies, brain slices from mice overexpressing
MeCP2 displayed an increase in paired pulse facilita-
tion and long-term potentiation (LTP) [24], while MeCP2
null mice exhibited the converse [7], suggesting that
MeCP2 expression may exert a profound role on synap-
tic plasticity. Our data indicate a specific deficit in excit-
atory synaptic transmission upon the loss of MeCP2
function. A recent study of cortical slices from 4- to 5-
week-old MeCP2 knockout mice also found changes inexcitatory, as well as inhibitory, transmission [6]. These
additional inhibitory changes may be specific for cortical
neurons, or they may just occur later in development.
Nevertheless, it appears that an imbalance in excitatory
and inhibitory input as we see in hippocampal cultures
may underlie some of the neurological deficits in RTT,
and possibly other related neurodevelopmental dis-
orders. Indeed, other recent studies have shown that
the neuroligin genes, a family of proteins implicated in
autism spectrum disorders, are important for maintain-
ing a balance of excitatory and inhibitory neurotransmis-
sion [25, 26].
It is worthwhile noting that we did not observe any
morphological changes in neurons lacking MeCP2.
This may well be due to the fact that our studies were
done in young cultures and may reflect a more immature
neuronal population. This suggests that the functional
deficits we observed in MeCP2 KO neurons may pre-
clude the neuronal structural abnormalities observed in
the disease state.
These data suggest that transcriptional repression is
important in regulatingpresynaptic functionofhippocam-
pal neurons. This provides insight into how the loss of
function of the transcriptional repressor, MeCP2, may
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715contribute to the disease state and may have profound
implications, especially if additional neuronal popula-
tions are under MeCP2 control. This information is im-
portant in delineating the cellular and functional abnor-
malities that lead to the wide array of neurological
deficits observed in RTT patients.
Experimental Procedures
Cell Culture
Whole hippocampi were dissected from the brains of 1-day-old
MeCP2 null knockout mice (Jackson Laboratories), floxed MeCP2
mice, or littermate controls, and dissociated cultures were prepared
according to previously published protocols [27]. For drug treatment
experiments, whole hippocampi were dissected from the brains of
1-day-old C57BL/6 mice and cultures prepared under identical con-
ditions. All experiments were performed on cultures 11–14 days
in vitro (DIV).
Drug Treatments and Cell Viability
Hippocampal cultures were treated for 24 hr at 10–11 DIV with the
following drugs: dimethyl sulfoxide (DMSO) (1:1000), Trichostatin A
(TSA) (1mM), or Actinomycin D (Act D) (2.5mM). After drug treatments,
cell viability was checked by Trypan Blue exclusion (Sigma). The per-
centages of dead cells were not significantly different between con-
trol cultures (6.8%6 1.8% SEM, DMSO-treated) and cultures treated
with drugs (6.8% 6 1.1%, TSA, and 3.5% 6 1.8%, ActD).
Immunocytochemistry
Dissociated hippocampal neurons were fixed for 30 min with 4%
paraformaldehyde, rinsed twice with 13 PBS/Glycine, then blocked
in 2% goat serum for 1 hr. The cells were then incubated with primary
antibodies, anti-MAP2 monoclonal (1:200, Chemicon), and anti-syn-
apsin polyclonal (1:1000, Synaptic Systems) overnight at 4ºC. The
next day the cells were washed, then incubated with fluorescent
secondary antibodies, goat-anti-rabbit (1:200, Molecular Probes),
and goat-anti-mouse (1:200, Molecular Probes). Coverslips were
mounted with Vectashield (Vector Laboratories) and neurons were
visualized on a Zeiss Confocal microscope.
Electrophysiology
Synaptic activity was recorded from hippocampal pyramidal cells by
a whole-cell voltage clamp technique. Data were acquired with an
Axopatch 200B amplifier and Clampex 8.0 software (Axon Instru-
ments). Recordings were filtered at 2 kHz and sampled at 200 ms.
Tyrode solution was identical as previously described [27], and
a hypertonic Tyrode solution was made by adding 500 mM sucrose.
The pipette internal solution contained (in mM): 115 Cs-MeSO3, 10
CsCl, 5 NaCl, 10 HEPES, 0.6 EGTA, 20 TEA-Cl, 4 Mg-ATP, 0.3 Na3GTP
(pH 7.35) (300 mOsm). The pipette solution for field stimulation also
contained 10 mM QX-314. Field stimulation was applied through
parallel platinum electrodes immersed in the perfusion chamber de-
livering 20 mA pulses.
Fluorescence Imaging
Synaptic boutons were loaded with FM1-43 during a 90 s incubation
in Tyrode solution containing 47 mM K+. After washing with a dye-
free Tyrode solution for 10 min, synaptic terminals were destained
with a 90 mM K+ Tyrode solution. All staining and washing solutions
contained 10 mM CNQX and 50 mM AP-5 to prevent recurrent activity.
Isolated boutons were selected during the wash and fluorescence
changes were measured during destaining. Images were obtained
by a cooled, intensified digital CCD camera (Roper Scientific) during
illumination (1 Hz and 40 ms) at 480 nm via an optical switch (Sutter
Instruments). Images were acquired and analyzed with Axon Imaging
software (Axon Instruments).
Lentivirus Production
HEK 293 cells were transfected with the Fugene 6 transfection sys-
tem (Roche Molecular Biochemicals) with the expression plasmid,
pFUGW or pFUGW-Cre, and two helper plasmids, delta 8.9 and
vesicular stomatitis virus G protein, at 3 mg of each DNA per 75 cm2
flask [28]. After 48 hr, lentivirus containing culture medium washarvested, filtered at a 0.45 mm pore size, and immediately used for
infection. Hippocampal cultures were infected at 7 DIV by adding
300 ml of viral suspension to each well, and recordings were done
13–14 DIV. Titer was determined by counting the number of infected
neurons per coverslip (high: >80%; low: <20%).
Statistical Analysis
All data in bar graphs were tested for statistical significance by
means of a two-tailed Student’s t test. Data included in cumulative
histograms were statistically analyzed by the Kolmogorov-Smirnov
test.
Supplemental Data
The Supplemental Figure can be found with this article online at
http://www.current-biology.com/cgi/content/full/16/7/710/DC1/.
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